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Burkholderia pseudomallei is not represented in the current version of Bruker Biotyper
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF
MS) system. A total of 66 isolates of B. pseudomallei, including 30 clinical isolates
collected from National Taiwan University Hospital (NTUH, n = 27) and Peking Union
Medical College Hospital (PUMCH, n = 3), and 36 isolates of genetically confirmed
strains, including 13 from clinical samples and 23 from environmental samples, collected
from southern Taiwan were included in this study. All these isolates were identified by
partial 16S rDNA gene sequencing analysis and the Bruker Biotyper MALDI-TOF MS
system. Among the 30 isolates initially identified as B. pseudomallei by conventional
identification methods, one was identified as B. cepacia complex (NTUH) and three
were identified as B. putida (PUMCH) by partial 16S rDNA gene sequencing analysis and
Bruker Biotyper MALDI-TOF MS system. The Bruker Biotyper MALDI-TOF MS system
misidentified 62 genetically confirmed B. pseudomallei isolates as B. thailandensis or
Burkholderia species (score values, 1.803–2.063) when the currently available database
(DB 5627) was used. However, using a newly created MALDI-TOF MS database
(including B. pseudomallei NTUH-3 strain), all isolates were correctly identified as B.
pseudomallei (score values >2.000, 100%). An additional 60 isolates of genetically
confirmed B. cepacia complex and B. putida were also evaluated by the Bruker Biotyper
MALDI-TOF MS system using the newly created database and none of these isolates
were identified as B. pseudomallei. MALDI-TOF MS is a versatile and robust tool for the
rapid identification of B. pseudomallei using the enhanced database.
Keywords:Burkholderia pseudomallei,B. thailandensis, matrix-assisted, laser desorption/ionization time-of-flight
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INTRODUCTION
Melioidosis is a tropical and subtropical infectious disease caused
by Burkholderia pseudomallei, a Gram-negative, aerobic, motile
rod-shaped bacterium that is widely distributed in rice field
soil, and in stagnant water throughout the tropics (Hsueh et al.,
2001; Currie et al., 2008; Lau et al., 2014). B. pseudomallei
is also a major cause of community-acquired septicemia and
pneumonia in adults in the Asia-pacific region, particularly in
northeast Thailand (Peto et al., 2014). In Taiwan, the first case
of melioidosis was reported in 1985 in a man who acquired the
disease after aspirating river water in a near-drowning accident
in the Philippines (Lee et al., 1985) Since then several sporadic
and epidemic cases have been reported (Hsueh et al., 2001; Ko
et al., 2007; Su et al., 2011; Chen et al., 2013, 2014). Previous
studies clearly showed that the disease was endemic in Taiwan
and demonstrated that all clinical isolates were arabinose non-
assimilators (Hsueh et al., 2001; Chen et al., 2013). Other studies
have reported high concentrations of ambient B. pseudomallei
during typhoon season in regions of Taiwan (Ko et al., 2007;
Su et al., 2011; Chen et al., 2014). Several typhoon-related
melioidosis epidemics have also been reported (Ko et al., 2007;
Su et al., 2011). There is also evidence that melioidosis can be
transmitted to humans via environmental aerosols contaminated
with B. pseudomallei (Chen P. S. et al., 2015).
In Mainland China, melioidosis was first reported in 1990
(Yang, 2000) and is now known to be endemic to several tropical
provinces, including Hainan, Guangdong, and Guangxi (Chen
H. et al., 2015; Fang et al., 2015; Zheng et al., 2015). Multilocus
sequence typing (MLST) disclosed that B. pseudomallei ST562
is dominant in southern China as well as in Australia and
Taiwan and that its wide-ranging presence might be due to recent
spread caused by transmission between regions (Chen H. et al.,
2015). Whole-genome sequencing of B. pseudomallei has been
conducted for isolates obtained from patients with melioidosis in
Mainland China (strain BPC006) and Taiwan (strain vgh07; Fang
et al., 2012; Chen Y. S. et al., 2015).
MALDI-TOF MS is increasingly being used in clinical
microbiology laboratories to identify bacterial isolates to the
species level and the technique is expected to further accelerate
the routine identification of suspicious isolates (Bizzini and
Greub, 2010; Inglis et al., 2012; Lau et al., 2012; Niyompanich
et al., 2014; Jang et al., 2015; Lasch et al., 2015). Because diseases
due to B. pseudomallei are uncommon in North America and
Europe, B. pseudomallei are not included (but B. thailandensis
was included) in the reference spectra of the Bruker Biotyper and
Vitek MS libraries (SARAMIS database) (Jang et al., 2015).
In the present study, we evaluated the ability of the
Bruker Biotyper MALDI-TOF MS system to accurately identify
genetically confirmed B. pseudomallei that were recovered from
patients and environmental sources.
MATERIALS AND METHODS
Bacterial Isolates
A total of 66 isolates of B. pseudomallei, including 43 clinical
isolates and 23 environmental isolates, were collected for study.
Among these isolates, 27 were recovered from patients with
bloodstream infections who were treated at National Taiwan
University Hospital (NTUH, a 2500-bed university-affiliated
hospital in northern Taiwan) during the period 1998–2014
(Table 1), and three isolates were recovered from patients treated
at Peking Union Medical College Hospital (PUMCH), Beijing,
China. The other 36 isolates of B. pseudomallei, which had been
identified by sequencing of the 16S rRNA and flagellar genes
(Chen et al., 2013), included 13 isolates from various clinical
samples obtained from patients treated at several hospitals
in southern Taiwan and 23 isolates obtained from different
environmental sources during the period 1994–2013 (Table 2;
Chen et al., 2013). Cultures and analysis of B. pseudomallei
isolates were manipulated in the Mycobacteriology Laboratory at
NTUH, a biosafety level 3 laboratory, and followed the biosafety
level 3 precaution. Identification of these isolates were initially
based on conventional biochemical methods and commercial
identification systems, including API (API 20E) and Vitek 2
(ID-GN card) (bioMe’rieux, Marcy l’Etoile, France). Arabinose
assimilation testing was performed for all genetically confirmed
B. pseudomallei isolates as reported previously (Hsueh et al.,
2001).
Identification of Isolates by Gene
Sequencing Analysis
Partial 16S rRNA gene sequencing of all 66 isolates was
performed using two primers, 8FPL (5′-AGAGTTT
GATCCTGGCTCAG-3′) and 1492RPL (5′-GGTTACCTTG
TTACGACTT-3′; Cheng et al., 2015). The sequences (1425
bp) obtained were compared with published sequences
in the GenBank database using the BLAST algorithm
(http://www.ncbi.nlm.nih.gov/blast).
Identification of Isolates by the Bruker
Biotyper MALDI-TOF System
Samples of the 66 isolates were prepared for analysis by the
Bruker BiotyperMALDI-TOFMS system as previously described
(Cheng et al., 2015). B. thailandensis E264 (ATCC700388) was
included as the control strain. All isolates were inoculated onto
Trypticase soy agar with 5% sheep blood (blood agar plates,
BAP; Becton DickinsonMicrobiology Systems Sparks, MD, USA)
and incubated in 5% CO2 at 37
◦C for 18 to 24 h. Two to three
colonies were transferred to a 1.5-ml screw-cap Eppendorf tube
containing 50µl of 70% formic acid. After incubation for 30 s,
50µl of acetonitrile (Sigma-Aldrich) was added. The suspension
was centrifuged at 13,000 rpm for 2 min, and then 1.0µl of
the supernatant was applied to a 96-spot polished steel target
plate (Bruker Daltonik GmbH) and dried. A saturated solution
of 1.0µl of MALDI matrix (alphacyano-4-hydroxycinnamic acid
matrix solution; Bruker Daltonik GmbH) was applied to each
sample and dried. Measurements were performed with the
Bruker Biotyper MALDI-TOF MS system using FlexControl
software with Compass Flex Series version 1.3 software and
a 60-Hz nitrogen laser (337 nm wavelength). Spectra ranging
from 2000 to 20,000 m/z were analyzed using the MALDI
Biotyper system’s automation control and the current Bruker
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TABLE 1 | Results of 16S rRNA sequencing analysis and Bruker Biotyper MALDI TOF MS for the identification of 26 isolates of B. pseudomallei recovered
from patients who were treated at National Taiwan University Hospital (NTUH).
No. (NTUH) Year of isolation Identification by 16S rRNA sequencing analysis Identification by Bruker Biotyper MALDI TOF MS system
Species Accession no. Database (DB 5627) New database (NTUH-3 strain)
(% of identity) (best match)
Organism Score Organism Score
(best match) value (best match) value
1. 1998 B. pseudomallei (100) CP004043.1 B. thailandensis 2.063 B. pseudomallei 2.15
2. 1998 B. pseudomallei (100) CP004043.1 B. thailandensis 1.913 B. pseudomallei 2.228
3. 1998 B. pseudomallei (100) CP004043.1 B. thailandensis 2.036 B. pseudomallei 2.318
4. 1999 B. pseudomallei (100) CP004043.1 B. thailandensis 1.974 B. pseudomallei 2.257
5. 1999 B. pseudomallei (100) CP004043.1 B. thailandensis 1.993 B. pseudomallei 2.332
6. 2000 B. pseudomallei (100) CP004043.1 B. thailandensis 1.907 B. pseudomallei 2.161
7. 2000 B. pseudomallei (100) CP004043.1 B. thailandensis 1.907 B. pseudomallei 2.117
8. 2000 B. pseudomallei (100) CP004043.1 B. thailandensis 1.899 B. pseudomallei 2.266
9. 2000 B. pseudomallei (100) CP004043.1 B. thailandensis 1.938 B. pseudomallei 2.075
10. 2000 B. pseudomallei (100) CP004043.1 B. thailandensis 1.934 B. pseudomallei 2.063
11. 2001 B. pseudomallei (100) CP004043.1 B. thailandensis 1.933 B. pseudomallei 2.055
12. 2001 B. pseudomallei (100) CP004043.1 B. thailandensis 1.996 B. pseudomallei 2.252
13. 2001 B. pseudomallei (100) CP004043.1 B. thailandensis 1.808 B. pseudomallei 2.017
14. 2001 B. pseudomallei (100) CP004043.1 B. thailandensis 1.941 B. pseudomallei 2.043
15. 2001 B. pseudomallei (100) CP004043.1 B. thailandensis 1.936 B. pseudomallei 2.09
16. 2001 B. pseudomallei (100) CP004043.1 B. thailandensis 2.016 B. pseudomallei 2.077
17. 2001 B. pseudomallei (100) CP004043.1 B. thailandensis 1.803 B. pseudomallei 2.113
18. 2001 B. pseudomallei (100) CP004043.1 B. thailandensis 1.898 B. pseudomallei 2.235
19. 2003 B. pseudomallei (100) CP004043.1 B. thailandensis 1.946 B. pseudomallei 2.27
20. 2003 B. pseudomallei (100) CP004043.1 B. thailandensis 1.865 B. pseudomallei 2.147
21. 2004 B. pseudomallei (100) CP004043.1 B. thailandensis 1.971 B. pseudomallei 2.308
22. 2004 B. pseudomallei (100) CP004043.1 B. thailandensis 2.002 B. pseudomallei 2.303
23. 2005 B. pseudomallei (100) CP004043.1 B. thailandensis 1.968 B. pseudomallei 2.221
24. 2008 B. pseudomallei (100) CP004043.1 B. thailandensis 2.013 B. pseudomallei 2.221
25. 2014 B. pseudomallei (100) CP004043.1 B. thailandensis 2.013 B. pseudomallei 2.176
26. 2014 B. pseudomallei (100) CP004043.1 B. thailandensis 2.013 B. pseudomallei 2.307
Biotyper 3.1 software and library (database [DB] 5627 with
5627 entries). Identification scores of ≥2.000 indicated species-
level identification, scores of 1.700 to 1.999 indicated genus-
level identification, and scores of <1.700 indicated no reliable
identification. B. pseudomallei is not listed in the current Bruker
Biotyper MALDI-TOF MS database.
Cluster Analysis and Main Spectra
Projection by the Bruker Biotyper MALDI
TOF System
A clustering analysis of 26 isolates collected from NTUH was
performed using ClinProTools 3.0 (Bruker Daltonics GmbH,
Bremen, Germany; Cheng et al., 2015). Dendrograms from the
MALDI Biotyper data of 26 genetically well-characterized B.
pseudomallei isolates were obtained and cluster groups with a
default critical distance level of 850 were identified. Isolates
from different cluster groups were selected for main spectra
projection (MSP; database entrance) creation using MALDI
Biotyper software (Bruker Daltonics). The database generated
using the isolates selected from different cluster groups was
blindly tested against the 26 B. pseudomallei isolates fromNTUH.
External validation was performed for another 36 B.
pseudomallei isolates collected from southern Taiwan, 30 isolates
of B. putida collected from NTUH (n = 10) and PUMCH
(n = 20), and 30 isolates of B. cepacia complex (from
NTUH). Principal component analysis (PCA) dendrograms were
generated from MALDI-TOF MS Biotyper mass spectra of 62
isolates of B. pseudomallei, including 42 clinical isolates and 20
environmental isolates.
RESULTS
Among the 30 clinical isolates collected from clinical
microbiology laboratories at the NTUH and PUMCH that
were initially identified as B. pseudomallei (all >90% probability)
by the Vietk 2 ID-GN card, four (one for NTUH and three
from PUMCH) were identified as non-B. pseudomallei by partial
16S rDNA sequencing analysis. Among these four isolates,
one was identified as B. cepacia complex (NTUH) and three
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TABLE 2 | Identification of 36 isolates of B. pseudomallei obtained from clinical specimens and environmental sources by Bruker Biotyper MALDI-TOF
MS with the NTUH-3 strain.
No Year of isolation Source Type of infection or
environmental sources
Identification results by Bruker
Biotyper MALDI TOF MS system
(NTUH-3 strain)
27 1994 Human Mycotic aneurysm (thoracic aorta) 2.545
28 1995 Human Septic pulmonary emboli 2.375
29 1996 Human Osteomyelitis, subcutaneous
abscess
2.259
30 1996 Human Pneumonia 2.405
31 1996 Human Osteomyelitis 2.509
32 1996 Human Primary bacteremia 2.529
33 1996 Human Hepatosplenic abscess 2.482
34 1996 Human Hepatosplenic abscess 2.398
35 1996 Human Hepatosplenic abscess 2.449
36 1998 Human Hepatic abscesses 2.567
37 2001 Human Mycotic aneurysm (thoracic aorta) 2.517
38 2001 Human Septicemia 2.318
39 2001 Human Multiple abscesses 2.506
40 2011 Soil Farm-1 (60 cm below surface) 2.470
41 2011 Soil Farm-1 (30 cm below surface) 2.626
42 2011 Soil Lawn (10 cm below surface) 2.508
43 2011 Soil Lawn (60 cm below surface) 2.436
44 2011 Soil Lawn (30 cm below surface) 2.461
45 2011 Water Pond 2.537
46 2012 Soil Farm-1 (60 cm below surface) 2.425
47 2012 Soil Farm-1 (60 cm below surface) 2.509
48 2012 Soil Farm-1 (10 cm below surface) 2.511
49 2012 Soil Farm-1 (10 cm below surface) 2.315
50 2013 Aerosols Primary school 2.307
51 2013 Aerosols Primary school 2.479
52 2013 Aerosols Primary school 2.385
53 2013 Soil Farm-1 (60 cm below surface) 2.457
54 2013 Soil Farm-1 (60 cm below surface) 2.462
55 2013 Soil Farm-1 (60 cm below surface) 2.413
56 2013 Soil Farm-1 (60 cm below surface) 2.573
57 2013 Soil Farm-1 (60 cm below surface) 2.517
58 2013 Soil Farm-1 (60 cm below surface) 2.509
59 2013 Water Pond 2.561
60 2013 Water Pond 2.27
61 2013 Water Pond 2.436
62 2013 Water Pond 2.595
These isolates were identified as B. pseudomallei by sequencing of the 16S rRNA and flagellar genes (6).
were identified as B. pudita (PUMCH) by partial 16S rDNA
sequencing analysis.
The Bruker Biotyper MALDI-TOF MS system misidentified
all the 62 isolates of genetically confirmed B. pseudomallei as
B. thailandensis (seven isolates with a score value ≥2.000) or
Burkholderia species (19 with score values ranging from 1.803
to 1.996). However, arabinose assimilation testing showed that
all 62 isolates were arabinose non-assimilators, indicating that
these isolates were not B. thailandensis. Clustering analysis of
the 26 genetically confirmed isolates of B. pseudomallei collected
from NTUH by the Bruker Biotyper MALDI-TOF MS system
identified five cluster groups (Figure 1).
Because B. pseudomallei was not listed in the current Bruker
Biotyper MALDI-TOF MS database (DB5627), spectra of five
isolates, namely NTUH-3, NTUH-13, NTUH-14, NTUH-16,
and NTUH-17, were selected from each cluster group for MSP
(database entrance). The database generated using the five
isolates was blindly tested against the spectra of the remaining
57 isolates (21 from NTUH and 36 from southern Taiwan).
The best identification scores were found according to the
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FIGURE 1 | Principal component analysis (PCA) dendrogram generated
from Bruker Biotyper MALDI-TOF MS mass spectra of 26 clinical
isolates of B. pseudomallei collected from NTUH. The five arrows
indicate the MALDI spectra of the five B. pseudomallei isolates selected for
MSP (main spectra projection; database entrance) creation using MALDI
Biotyper software (Bruker Daltonics).
database created using the NTUH-3 strain; all (100%) 57 B.
pseudomallei isolates were correctly identified as B. pseudomallei
with identification scores of ≥2.000 (2.017 to 2.626). B.
thailandensis E264 (ATCC700388) was identified by the Bruker
Biotyper MALDI-TOF MS system based on Bruker Biotyper 3.1
software and library (DB5627) plus new database created by
NTUH-3 strain (enhanced database) as B. thailandensis (best
match, score value of 2.170) or B. pseudomallei (second match,
score value of 2.058). Among the four isolates initially mis-
identified as B. pseudomallei, one was identified as B. cepacia
complex (NTUH; score value of 2.137) and three were identified
as B. pudita (PUMCH; 2.012, 2.102, and 2.223, respectively)
by standard and enhanced Bruker Biotyper MALDI-TPOF
MS database. The characteristic spectra of NTUH-3 strain
and B. thailandensis E264 (ATCC700388) are shown in
Figure 2.
The PCA dendrogram generated from MALDI Biotyper mass
spectra of 62 isolates of B. pseudomallei, including 42 clinical
isolates and 20 environmental isolates collected from northern
and southern Taiwan is illustrated in Figure 3. There were five
cluster groups with dividing branches linked at a distance level
of 850.
Among the 30 isolates of genotypically characterized B. putida
and 30 isolates of B. cepacia complex, all were identified as
B. putida (score values of >2.000) and B. cepacia complex (26
B. cenocepacia and four B. cepacia; score values of >2.000),
respectively, using the pre-existing database and that created by
NTUH-3 strain.
DISCUSSION
This study revealed several important findings. First, the Bruker
Biotyper MALDI-TOF MS system failed to correctly identify
clinical and environmental isolates of B. pseudomallei because B.
pseudomallei is not listed in the current version of FDA-cleared
Bruker library. Although there is a “security-relevant library”
which contains B. pseudomallei, this library is not available
in most clinical microbiological laboratories. Second, when we
included the B. pseudomallei NTUH-3 strain only into the
current library, all isolates of B. pseudomallei could be identified
B. pseudomallei by the Bruker Biotyper MALDI-TOF MS system
with a correct identification rate of 100%. Third, the control
strain of B. thailandensis was still identified as B. thailandensis as
the best match organism when the enhanced database was used.
Finally, all isolates obtained from environmental sources were
confirmed to be B. pseudomallei not B. thailandensis.
Identification of B. pseudomallei poses difficulties in clinical
microbiology laboratories. Although, B. pseudomallei is included
in the API 20NE, the Vitek 1, and the Vitek 2 databases, the
accuracy of identification by these systems varies (Lau et al.,
2015). Misidentification of B. pseudomallei as other Burkholderia
species such as B. cepacia complex and B. putida as well as
Pseudomonas aeruginosa is common using these commercial
systems (around 20%; Lowe et al., 2006; Deepak et al., 2008;
Zong et al., 2012; Lau et al., 2015). Furthermore, commercial
bacterial identification kits might fail to differentiate between B.
pseudomallei and a closely related species such as B. thailandensis,
although >99% of cases of melioidosis are caused by B.
pseudomallei (Lau et al., 2015). The issue of misidentification
of B. pseudomallei is of importance for patient care as well as
laboratory safety.
Traditionally, B. pseudomallei can be distinguished from
B. thailandensis by arabinose assimilation (Lau et al., 2015).
Genotypic differentiation between B. pseudomallei and
B. thailandensis can be achieved by specific PCR-based
identification using B. pseudomallei-specific gene targets, such
as the Type III secretion system and Tat-domain protein and
sequencing of gene targets of 16S rRNA and groEL (Lau et al.,
2015).
MALDI-TOF MS, a revolutionary technique for pathogen
identification, has been shown to be a potentially useful tool
for rapid identification of B. pseudomallei, although existing
databases require optimization by adding reference spectra for B.
pseudomallei (Inglis et al., 2012; Lau et al., 2012; Niyompanich
et al., 2014; Lasch et al., 2015). Jang et al. reported a case
of multifocal aneurysms in the aortic arch of the thoracic
aorta and pseudoaneurysm in the abdominal aorta and the
inferior area of the superior mesenteric artery caused by B.
pseudomallei (Jang et al., 2015). Colonies from positive blood
and tissue were compatible with the presumptive identification
of B. pseudomallei. However, using the Vitek 2 system, the blood
isolate was identified as B. pseudomallei and the tissue isolate was
identified as B. cepacia complex. The blood isolate was identified
as B. thailandensis with a score value of 1.901 by the Bruker
Biotyper MALDI-TOF MS system (Jang et al., 2015). Lau et al.
used the Bruker database extendedwith B. pseudomallei reference
strains, three B. thailandensis isolates were misidentified as B.
pseudomallei. In this study, the reference strain of B. thailandensis
was correctly identified with enhanced Bruker database. More
isolates of B. thailandensis isolates are needed for verify the
accuracy of this new database.
Recently, bioMerieux recognized misidentification of B.
pseudomallei as an important issue and addressed the problem
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FIGURE 2 | Characteristic MALDI-TOF MS spectra. Characteristic spectra of (A) B. pseudomallei (NTUH-3 strain) and (B) B. thailandensis E264 (ATCC 700388)
generated by the Bruker Biotyper MALDI-TOF MS system. The absolute intensities of the ions are shown on the y axis, and the masses (m/z) of the ions are shown on
the x axis. The m/z values represent the mass-to-charge ratios.
FIGURE 3 | Principal component analysis (PCA) dendrogram of B. pseudomallei. PCA dendrogram generated from Bruker Biotyper MALDI TOF MS mass
spectra of the 62 isolates of B. pseudomallei, including 42 clinical isolates, and 20 environmental isolates collected from northern and southern Taiwan.
by altering the algorithm parameters. The new parameters are
included in the most recent software release (version 4.03 for
Vitek 2 60/XL and version 2.01 for Vitek 2 Compact; Lowe et al.,
2006).
Interestingly, in this study all four isolates initially identified as
B. pseudomallei by the Vitek 2 ID-GN card were identified as B.
cepacia complex or B. pudita by 16S rRNA sequencing analysis.
In areas with high endemicity of melioidoisis like Taiwan,
laboratory staff tends to report the results of B. pseudomallei
isolation without further clarification. In contrast, most clinical
microbiologists in Beijing often recheck the identification of B.
pseudomallei because of the low incidence of melioidoisis in
northern China (Yang, 2000; Currie et al., 2008; Fang et al., 2015;
Zheng et al., 2015).
SUMMARY
In areas where this organism is endemic, such as in South
Asia and Northern Australia, identification of B. pseudomallei
is not usually problematic (Currie et al., 2008; Lau et al., 2015).
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With increased international travel and threats of bioterrorism,
recognition, and accurate identification of these organisms is
important (Lau et al., 2015). The use of automated identification
systems, includingMALDI-TOFMS, in the clinical microbiology
laboratory is becoming common as the pressure of cost
containment impacts staff resources. In this study, using our
newly created database, all B. pseudomallei isolates were correctly
identified to the species level using the Bruker Biotyper MALDI-
TOF MS system. These findings suggest that MALDI-TOF MS
is a versatile and robust tool for the rapid identification of
B. pseudomallei isolates. Expansion of commercially available
databases with pathogens endemic in different regions is crucial
to improve the usefulness of MALDI-TOF MS. However, this
successful application of MALDI-TOF can only be regarded
as pilot study, due to the small sample size, which needs
independent validation before it can be offered as routine
technique in the clinic.
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